CardioVascular BioTherapeutics, Inc.
CardioVascular BioTherapeutics, Inc. (CVBT) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 227 transactions totaling $5.1M, demonstrating a bearish sentiment with -$3.6M in net insider flow. The most recent transaction on Aug 11, 2009 involved a sale of 218,693 shares valued at $59.0K.
CVBT Insider Activity Summary
Who Is Buying CVBT Stock?
No significant insider buying has been recorded for CVBT in the recent period.
Who Is Selling CVBT Stock?
No significant insider selling has been recorded for CVBT in the recent period.
Is CardioVascular BioTherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CVBT is bearish with an Insider Alignment Score of 15/100 and a net flow of -$3.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CVBT Frequently Asked Questions
Understanding CVBT Insider Activity
Insider trading at CardioVascular BioTherapeutics, Inc. (CVBT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading CVBT stock, having executed 227 transactions in the past 90 days. The most active insider is Thomas Stegmann (Executive), who has made 82 transactions totaling $2.2M.
Related Tools
Track CardioVascular BioTherapeutics, Inc. Insider Activity
Get notified when executives and directors at CVBT file new Form 4 transactions